Multicentre, Randomised, Double-blind, Placebo-controlled Parallel-group Dose-Finding Study of Herbal Medicine (Dry Extract) BNO-1016 in Acute Rhinosinusitis

Claus Bachert, Martin Mondigler, Hubert Steindl, Holger Stammer, Pontus Stierna, Herbert Eskötter & Rainer Jund
Background: The aim of rhinosinusitis therapy is amelioration of symptoms and restoration of ventilation of nose and paranasal sinuses. BNO-1016 is a novel extract of five herbal drugs which are marketed as Sinupret® extract for rhinosinusitis. Methods: In this randomised placebo-controlled[for full text, please go to the a.m. URL]